Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

354
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
354
Tumor Immunotherapy01:27

Tumor Immunotherapy

514
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
514
Overview of Exosomes01:36

Overview of Exosomes

2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Thin-Layer NbOCl<sub>2</sub> Flat-Band Semiconductor for Efficient PEC Photodetection.

The journal of physical chemistry letters·2026
Same author

Development and validation of prognostic nomograms for patients with cervical cancer and liver metastasis: a SEER-based study.

Translational cancer research·2026
Same author

VTA dopamine inputs activate accumbal D1 receptors to promote alcohol seeking.

iScience·2026
Same author

Policy and science at a crossroads: integrating new approach methodologies (NAMs) into anticancer drug testing frameworks.

Science bulletin·2026
Same author

A dual-pronged strategy for bacterial keratitis: ROS-responsive hydrogel eye drops enabling potent deep-tissue antibacterial action and NETs modulation.

Bioactive materials·2026
Same author

Clinical diagnosis and treatment for well-differentiated liposarcoma: A clinical practice guideline.

Innovation (Cambridge (Mass.))·2026

Related Experiment Video

Updated: Jun 24, 2025

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells
08:02

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells

Published on: September 23, 2021

2.5K

Exosome-based anticancer vaccines: From Bench to bedside.

Guo Zhao1, Yuning Wang1, Shujun Xing1

  • 1Clinical Trial Center, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.

Cancer Letters
|June 2, 2024
PubMed
Summary

Exosomes, tiny cell-derived vesicles, are promising for cancer immunotherapy and drug delivery due to their unique properties. This review explores exosome-based cancer vaccines and their clinical potential.

Keywords:
Cancer vaccinesClinical translationExosomesImmunotherapyTumor immunity

More Related Videos

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

9.5K
Preparation of Exosomes for siRNA Delivery to Cancer Cells
09:59

Preparation of Exosomes for siRNA Delivery to Cancer Cells

Published on: December 5, 2018

25.1K

Related Experiment Videos

Last Updated: Jun 24, 2025

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells
08:02

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells

Published on: September 23, 2021

2.5K
Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

9.5K
Preparation of Exosomes for siRNA Delivery to Cancer Cells
09:59

Preparation of Exosomes for siRNA Delivery to Cancer Cells

Published on: December 5, 2018

25.1K

Area of Science:

  • Cell Biology
  • Immunology
  • Biotechnology

Background:

  • Exosomes are key mediators of intercellular communication, transferring molecules like DNA, RNA, and proteins.
  • Their non-toxic, low-immunogenic, and stable nature makes exosomes ideal for drug development.
  • Tumor and immune cell-derived exosomes have distinct compositions crucial for anticancer immunotherapy.

Purpose of the Study:

  • To summarize exosome biogenesis, structure, composition, and functions.
  • To describe the role of exosomes in cancer biology and tumor immunity.
  • To review exosome-based anticancer vaccine development and clinical translation.

Main Methods:

  • Literature review of exosome biology and function.
  • Analysis of exosome roles in cancer immunity.
  • Categorization and review of exosome-based anticancer vaccine strategies.

Main Results:

  • Exosomes facilitate intercellular communication and molecule transfer.
  • Exosomes play significant roles in tumor immunity and immune regulation.
  • Three main types of exosome-based anticancer vaccines have been developed.

Conclusions:

  • Exosome-based immunotherapy shares therapeutic goals with cancer vaccines.
  • Challenges remain for the clinical application of exosome-based therapies.
  • Further research into clinical translation and trials is essential for exosome-based anticancer vaccines.